mRNA |
ML006 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.008 |
mRNA |
lapatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.096 |
0.01 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.01 |
mRNA |
BRD-M00053801 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.01 |
mRNA |
Bosutinib |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.01 |
mRNA |
Compound 7d-cis |
CTRPv2 |
pan-cancer |
AAC |
0.096 |
0.01 |
mRNA |
RITA |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.01 |
mRNA |
ML239 |
CTRPv2 |
pan-cancer |
AAC |
0.089 |
0.02 |
mRNA |
SB-525334 |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.02 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.087 |
0.02 |